New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment
Descrição
In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
Post-acute COVID-19 syndrome
Does BCG vaccination protect against acute respiratory infections and COVID- 19? A rapid review of current evidence - The Centre for Evidence-Based Medicine
Long COVID NIH COVID-19 Research
Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases - ScienceDirect
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds - The New York Times
Evolution of 18F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation
New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment
Frontiers Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID- 19
What We Know about Long COVID—and What We Don't, The Brink
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
Study Is Investigating Role of Pituitary Hormone Deficiency in Post-COVID Fatigue
Long COVID and cardiovascular disease: a learning health system approach
de
por adulto (o preço varia de acordo com o tamanho do grupo)
